405 related articles for article (PubMed ID: 33340519)
1. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition.
Allen JD; Watanabe Y; Chawla H; Newby ML; Crispin M
J Mol Biol; 2021 Feb; 433(4):166762. PubMed ID: 33340519
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2.
Nguyen K; Chakraborty S; Mansbach RA; Korber B; Gnanakaran S
Viruses; 2021 May; 13(5):. PubMed ID: 34067878
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.
Rowland R; Brandariz-Nuñez A
Microbiol Spectr; 2021 Oct; 9(2):e0119921. PubMed ID: 34494876
[TBL] [Abstract][Full Text] [Related]
5. S494 O-glycosylation site on the SARS-CoV-2 RBD affects the virus affinity to ACE2 and its infectivity; a molecular dynamics study.
Rahnama S; Azimzadeh Irani M; Amininasab M; Ejtehadi MR
Sci Rep; 2021 Jul; 11(1):15162. PubMed ID: 34312429
[TBL] [Abstract][Full Text] [Related]
6. N-glycosylation of the SARS-CoV-2 spike protein at Asn331 and Asn343 is involved in spike-ACE2 binding, virus entry, and regulation of IL-6.
Das T; Luo S; Tang H; Fang J; Mao Y; Yen HH; Dash S; Shajahan A; Pepi L; Huang S; Jones VS; Xie S; Huang GF; Lu J; Anderson B; Zhang B; Azadi P; Huang RP
Microbiol Immunol; 2024 May; 68(5):165-178. PubMed ID: 38444370
[TBL] [Abstract][Full Text] [Related]
7. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike.
Mehdipour AR; Hummer G
Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33903171
[TBL] [Abstract][Full Text] [Related]
8. Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor.
Capraz T; Kienzl NF; Laurent E; Perthold JW; Föderl-Höbenreich E; Grünwald-Gruber C; Maresch D; Monteil V; Niederhöfer J; Wirnsberger G; Mirazimi A; Zatloukal K; Mach L; Penninger JM; Oostenbrink C; Stadlmann J
Elife; 2021 Dec; 10():. PubMed ID: 34927585
[TBL] [Abstract][Full Text] [Related]
9. ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV.
Acharya A; Lynch DL; Pavlova A; Pang YT; Gumbart JC
Chem Commun (Camb); 2021 Jun; 57(48):5949-5952. PubMed ID: 34019602
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2.
Shajahan A; Archer-Hartmann S; Supekar NT; Gleinich AS; Heiss C; Azadi P
Glycobiology; 2021 May; 31(4):410-424. PubMed ID: 33135055
[TBL] [Abstract][Full Text] [Related]
11.
Lapaillerie D; Charlier C; Fernandes HS; Sousa SF; Lesbats P; Weigel P; Favereaux A; Guyonnet-Duperat V; Parissi V
Viruses; 2021 Feb; 13(3):. PubMed ID: 33669132
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection.
Trbojević-Akmačić I; Petrović T; Lauc G
Glycoconj J; 2021 Oct; 38(5):611-623. PubMed ID: 34542788
[TBL] [Abstract][Full Text] [Related]
13. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
J Genet; 2021; 100(1):. PubMed ID: 33707363
[TBL] [Abstract][Full Text] [Related]
14. Rapid Profiling of the Glycosylation Effects on the Binding of SARS-CoV-2 Spike Protein to Angiotensin-Converting Enzyme 2 Using MALDI-MS with High Mass Detection.
Zhou Y; Tan C; Zenobi R
Anal Chem; 2024 Feb; 96(5):1898-1905. PubMed ID: 38279913
[TBL] [Abstract][Full Text] [Related]
15. Structural and Functional Analysis of Female Sex Hormones against SARS-CoV-2 Cell Entry.
Aguilar-Pineda JA; Albaghdadi M; Jiang W; Vera-Lopez KJ; Nieto-Montesinos R; Alvarez KLF; Davila Del-Carpio G; Gómez B; Lindsay ME; Malhotra R; Lino Cardenas CL
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768939
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
17. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor.
Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L
Cell Host Microbe; 2020 Oct; 28(4):586-601.e6. PubMed ID: 32841605
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.
Luan J; Jin X; Lu Y; Zhang L
J Med Virol; 2020 Sep; 92(9):1649-1656. PubMed ID: 32239522
[TBL] [Abstract][Full Text] [Related]
19. Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics.
Barton MI; MacGowan SA; Kutuzov MA; Dushek O; Barton GJ; van der Merwe PA
Elife; 2021 Aug; 10():. PubMed ID: 34435953
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets.
Raghuvamsi PV; Tulsian NK; Samsudin F; Qian X; Purushotorman K; Yue G; Kozma MM; Hwa WY; Lescar J; Bond PJ; MacAry PA; Anand GS
Elife; 2021 Feb; 10():. PubMed ID: 33554856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
